Trials / Completed
CompletedNCT00613587
Roflumilast In-Vitro Basophil Release
Effect of Roflumilast In-Vitro on Basophil Histamine, Leukotriene, IL-4 and IL13-release.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Creighton University · Academic / Other
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is looking for allergic asthmatics. Lung and allergy testing will be done to verify. If qualified, blood will be drawn for laboratory studies.
Detailed description
Non-smoking allergic asthmatics will be verified using pulmonary function, skin prick testing, exhaled nitric oxide and serum IgE. If qualified, blood will be drawn, treated with study medication and then stimulated with the allergen to which the subject is allergic. Mediators including Histamine, IL-13, IL-4, and leukotrienes will be measured.
Conditions
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2010-01-01
- Completion
- 2010-01-01
- First posted
- 2008-02-13
- Last updated
- 2012-10-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00613587. Inclusion in this directory is not an endorsement.